127 related articles for article (PubMed ID: 29499878)
1. Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases.
Agarwal JP; Chakraborty S; Laskar SG; Mummudi N; Patil VM; Upasani M; Prabhash K; Noronha V; Joshi A; Purandare N; Tandon S; Arora J; Badhe R
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):382-390. PubMed ID: 29499878
[TBL] [Abstract][Full Text] [Related]
2. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?
Langley RE; Stephens RJ; Nankivell M; Pugh C; Moore B; Navani N; Wilson P; Faivre-Finn C; Barton R; Parmar MK; Mulvenna PM;
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):e23-30. PubMed ID: 23211715
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
[TBL] [Abstract][Full Text] [Related]
5. A review of whole brain radiotherapy outcomes in a high epidermal growth factor receptor mutation rate population: Does QUARTZ apply in Asia?
Ng IW; Tey JCS; Chia DWT; Yee CM; Cheo TST
Asia Pac J Clin Oncol; 2019 Dec; 15(6):353-357. PubMed ID: 31267659
[TBL] [Abstract][Full Text] [Related]
6. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
[TBL] [Abstract][Full Text] [Related]
7. Confirmatory Analysis of QUARTZ Study Results: Survival Prolongation After Whole-brain Radiotherapy.
Nieder C; Dalhaug A; Pawinski A
Anticancer Res; 2020 Feb; 40(2):977-981. PubMed ID: 32014942
[TBL] [Abstract][Full Text] [Related]
8. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
10. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
[TBL] [Abstract][Full Text] [Related]
11. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous.
Nieder C; Guckenberger M; Gaspar LE; Rusthoven CG; De Ruysscher D; Sahgal A; Nguyen T; Grosu AL; Mehta MP
Radiat Oncol; 2019 Feb; 14(1):33. PubMed ID: 30770745
[TBL] [Abstract][Full Text] [Related]
13. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
[TBL] [Abstract][Full Text] [Related]
14. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
15. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
Dinglin XX; Ma SX; Wang F; Li DL; Liang JZ; Chen XR; Liu Q; Zeng YD; Chen LK
Clin Lung Cancer; 2017 May; 18(3):e179-e186. PubMed ID: 28185793
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.
Yang RF; Yu B; Zhang RQ; Wang XH; Li C; Wang P; Zhang Y; Han B; Gao XX; Zhang L; Jiang ZM
Braz J Med Biol Res; 2017 Nov; 51(1):e6073. PubMed ID: 29185589
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
